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Abstract. Advances in optical designs are enabling the development of miniature microscopes that can examine tissue in situ
for early anatomic and molecular indicators of disease, in real time, and at cellular resolution. These new devices will lead to
major changes in how diseases are detected and managed, driving a shift from today’s diagnostic paradigm of biopsy followed
by histopathology and recommended therapy, to non-invasive point-of-care diagnosis with possible same-session definitive
treatment. This shift may have major implications for the training requirements of future physicians to enable them to interpret
real-time in vivo microscopic data, and will also shape the emerging fields of telepathology and telemedicine. Implementation
of new technologies into clinical practice is a complex process that requires bridging gaps between clinicians, engineers and
scientists. This article provides a forward-looking discussion of these issues, with a focus on malignant and pre-malignant
lesions, by first highlighting some of the clinical areas where point-of-care in vivo microscopy could address unmet needs, and
then by reviewing the technological challenges that are being addressed, or need to be addressed, for in vivo microscopy to
become a standard clinical tool.
Keywords: In vivo microscopy, molecular imaging, biomedical optics, microendoscopy, endomicroscopy, optical sectioning,
optical biopsy, biomarker, cancer, dysplasia, image-guided therapy, telepathology
1. Introduction
1.1. Rationale for in vivo microscopy
Microscopic observation of tissue specimens—
prepared according to established protocols in histol-
ogy for fixation, embedding, sectioning and staining—
is regarded by the medical community as a highly
reliable method for the diagnosis of disease and is
∗Corresponding author: Jonathan T.C. Liu, Bioengineering G15,
Stony Brook, NY 11794, USA. Tel.: +1 631 632 1727 (W) and +1
631 632 3222 (F); E-mail: jonathan.liu@stonybrook.edu.
the current standard of care. The science and art of
histopathology is based upon the observation of devi-
ations from normal cellular and nuclear morphology,
cellular orientation (polarity) and density, as well as
an assessment of overall tissue architecture and cel-
lular composition. Immunohistochemistry and in situ
hybridization enable high-resolution localization of
protein or nucleic acid markers of disease, respec-
tively, with reasonable specificity and sensitivity.
While molecular testing in the absence of morphol-
ogy, via PCR or flow cytometry, for example, also
has value in the detection, diagnosis, and monitoring
of human malignancy, morphologic visualization of
2210-7177/11/$27.50 © 2011 – IOS Press and the authors. All rights reserved
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human tissue will continue as the clinical standard for
diagnosis of cancer and pre-cancerous conditions for
the foreseeable future.
Despite its acceptance as the standard-of-care, there
are limitations to conventional histopathologic diagno-
sis. First is the need to perform an invasive biopsy or
resection procedure. Second is its dependence on the
ability of the human observer (typically, the pathol-
ogist) to make reliable judgments, both as a single
observer over time (“intra-observer variation”) and
between different observers (“inter-observer varia-
tion”). A third issue is the sampling of tissue itself,
which depends on removing the appropriate tissue
from the patient and then selecting and microscopically
reviewing the most relevant portions of the biopsied
material. A fourth concern relates to possible arti-
facts introduced during processing that can impair
morphological and/or molecular interpretation. These
artifacts include sample desiccation, shrinkage caused
by fixation and embedding in non-aqueous materials,
and differential loss or alteration of molecular con-
stituents. In short, devitalized tissue sections mounted
on glass slides provide pathologists with a limited
two-dimensional cross-section of what was once living
three-dimensional tissue.
In contrast, we will describe the potential advan-
tages, challenges, and implications of what can be
called “point-of-care pathology (POCP),” which con-
sists of real-time morphologic examination, at the
cellular level, of living tissues in their native con-
text. Due to space constraints, we will not discuss
non-image-based techniques, such as varieties of
light-scattering characterization, or reflectance and flu-
orescence spectroscopy.
In situ examination circumvents the need for ex
vivo tissue processing, a key source of variability in
the era of molecular diagnostics. While in situ sam-
pling error remains a potential problem, and in vivo
molecular imaging has its own set of challenges, POCP
has the potential to provide immediate assessment
of disease status, improve diagnostic accuracy, guide
tissue biopsies, and accelerate diagnostic and thera-
peutic processes. This development may even permit
identification of new molecular and functional signa-
tures of cancer. For example, real-time microscopic
visualization of blood flow or the transport of con-
trast agents could provide early physiological evidence
(functional biomarkers) of malignant transformation
prior to the onset of altered morphology [1]. In addi-
tion, techniques that require no exogenous molecular
probes—relying only on the intrinsic optical properties
of tissue such as autofluorescence, light-scattering, or
fluorescence lifetime—are highly sensitive to environ-
mental properties such as hydration, pH, oxygenation,
and electrolyte concentration, and are ideally per-
formed in situ [2–6].
If exogenous agents are to be used for molecularly
specific diagnosis, staging, and typing of diseases, they
can be chosen from a large number of probes under
development [7–9]. Advanced, activatable probes have
the desirable property of only switching “on” (i.e.,
generating a signal) when they have reached their tar-
get, thereby improving signal-to-background ratios [7,
10–14]. In addition, optical imaging is ideally suited
for the simultaneous detection of multiple probes,
each emitting and/or absorbing light at a different
wavelength [15]. These advanced agents can provide
optical contrast and report on both the molecular con-
tent and environment of living tissue, and thus have
the unique potential to advance the field of point-of-
care pathology. However, given the enormous scope
of this specific topic, including the challenges posed
by obtaining regulatory approval, and the fact that
such reagents have recently been reviewed elsewhere
[7–13], we will not discuss them further.
1.2. Clinical paradigms
The simplest view of in vivo pathology is that the
proceduralist (endoscopist, surgeon, or other) obtains
diagnostic morphologic information in real time and
relies only on the in vivo morphologic findings to
make on-the-spot decisions about patient management
and intervention. In vivo microscopy would thus move
morphologic assessment from post-procedure to intra-
procedure, fundamentally changing the interactions
of the healthcare team with the patient. In the case
of endoscopy, either the endoscopist (e.g., gastroen-
terologist or surgeon) and the pathologist would have
to interact during the procedure in ways that do not
impose delays, or the endoscopist would have to make
her/his own assessments:
1) In the first instance, the endoscopist and the
pathologist are independent practitioners. Short of hav-
ing the pathologist in the procedure room, as has been
practiced for rapid diagnosis of needle aspirations, this
model demands a telepathology approach, whereby
digital image data are transmitted to a remote location
for processing and interpretation (Fig. 1) [16, 17]. In
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Fig. 1. An example of how point-of-care pathology, via endoscopic microscopy, may be incorporated into the clinical workflow for the detection
of gastrointestinal diseases. Option 1 depicts the proceduralist and pathologist working as a team. Option 2 depicts the proceduralist working
by her/himself, possibly with the aid of automated image processing tools. See text for details.
this scenario, the endoscopist must manage the patient
during the procedure, utilize the in vivo microscopy
instrumentation, and respond to interpretations from an
off-site colleague. This first model provides for a dedi-
cated and specialized pathologist reviewing the stream
of morphologic data arising during the course of a pro-
cedure. This first model also has the advantage of a
team of physicians – either a proceduralist and pathol-
ogist, or a team of off-site pathologists – conferring on
a diagnosis.
2) In the second scenario, the endoscopist also
serves as the on-site morphologist. This model assumes
that there are sufficient advantages in having a single
individual filling both roles. Three fundamental con-
cerns arise: would the single individual have sufficient
morphologic expertise; would that individual be able
to apply that expertise competently in the midst of
managing the patient during the procedure; and what
quality-control review processes would be in place?
Regardless of the model, medical management could
be essentially instantaneous, including the decision to
obtain a confirmatory tissue biopsy and/or to insti-
tute intra-procedural treatment. Under either scenario,
a key disadvantage is that point-of-care pathology, and
possibly intervention, would extend the duration of the
procedure, exposing the patient to prolonged physio-
logic stress and extended anesthesia time, and reducing
the productivity of the proceduralist and pathologist
alike. This disadvantage would have to be outweighed
by the value of real-time diagnosis and intervention,
so that the patient would obtain more timely care and
might avoid additional invasive procedures.
Major efforts are underway to develop automated
image-processing algorithms for the analysis of digi-
tal pathology images, including those obtained on fresh
tissues with miniature microendoscopes [18–20]. Such
approaches have the benefit of being able to integrate
multiple parameters, either contained within a given
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image, or accessed across multiple imaging modalities
(Fig. 1). Adding to the potential value of an auto-
mated evaluation, clinical and biochemical data can
also be folded into decision-support algorithms [21].
Part of the motivation for these efforts is the con-
cept that in vivo pathology may contain morphologic
and functional information beyond what one individ-
ual trained in traditional morphologic methods can
interpret. In addition, integrating multiple information
sources quickly enough to guide intra-procedural deci-
sion making could be taxing even for two collaborating
physicians (proceduralist and pathologist) on a case.
With that in mind, it is worth noting that relevant real-
time optical information obtained during the procedure
should be captured for possible post-review, either as
“snap-shots” and/or as a continuous digital record.
Regardless of clinical practice model, applications
in which in vivo pathology could add value may be
broadly categorized as either image-guided biopsy or
image-guided therapy:
1) Image-guided biopsy is an obvious step towards
transitioning from traditional histopathology to in vivo
pathology, as it uses the latter to enhance the former
rather than to replace it. An example application is
screening patients with Barrett’s esophagus, in which a
geographic survey involving potentially dozens of ran-
dom biopsies is currently used as a means to screen for
the dysplastic transformations that precede esophageal
cancer [22]. Beyond the fact that these “saturation”
biopsies create a whole set of iatrogenic esophageal
ulcers, cost concerns related to the reimbursement of
multiple histopathologic tissue samples have also led to
a pernicious issue: pooling of multiple tissue biopsies
into sample jars. Such pooling reduces the opportu-
nity to track the location of each biopsy. Identification
through in vivo microscopy of tissue sites of great-
est concern would lessen the need for a high number
of physical biopsies and reduce the need for pooling
of biopsy samples. In vivo microscopy would allow
more sites to be noninvasively sampled in real time,
thus reducing sampling errors. Lastly, image-guided
biopsy would potentially draw advantage from both
the real-time assessment of in vivo microscopy, and
the reliability of follow-up histopathology.
2) Image-guided therapy (i.e., definitive treatment)
currently relies on correlating pre-procedure MRI and
CT images with findings inside the patient at the time of
procedure. While the optimal spatial resolution of MRI
and CT is on the millimeter scale, disease-to-normal
contrast is only modest. Furthermore, significant spa-
tial deformations often occur between the time of MRI
and CT imaging and a procedure. Hence, the ability
of such imaging to guide a therapeutic intervention
is limited [21]. In contrast, in vivo microscopy has
the potential to improve therapeutic/surgical accuracy
in a direct fashion, through the real-time observation
of cellular and subcellular morphology, function, and
molecular expression, and the ability to more precisely
obtain biopsy specimens if they are required.
However, it is important to consider the poten-
tial limitations of in-vivo microscopy when medical
decisions are made in the absence of confirmatory
histologic evaluation of tissue. For example, if the
intra-procedural decision is not biopsy but immediate
treatment (e.g., through localized freezing or heating),
the imaged tissue may be obliterated. Intra-procedural
diagnostic error may thus remain undetected, lead-
ing either to inappropriate or unnecessary therapeutic
intervention, and/or the failure to follow a different
management path of greater benefit to the patient. Even
with the development of highly reliable and validated
technologies for in vivo microscopy, rigorous quality
management must be instituted, to ensure both appro-
priate use of the technology, and the competence of the
healthcare practitioners (proceduralist and pathologist
alike) in an ongoing fashion. Second, the inherent arti-
facts of histopathology, such as tissue shrinkage, are
an almost unconscious part of the knowledge founda-
tion for pathologists. Morphologic assessment of living
tissues will require establishment of a new interpretive
skill set, particularly since the artifacts introduced by
devitalization and fixation will be absent. Until new
image-to-disease correlations are established, there is
potentially enhanced risk of interpretive error of in vivo
microscopic images.
1.3. Bridging the gap between technology
and practice
There is often a disconnect between the engineers
and scientists who develop new medical technolo-
gies – and who are often largely technically driven –
and clinical end-users, whose potential adoption of
new methods will be guided by very different incen-
tives. Therefore, for the remainder of this article, we
seek to do two things. First, we attempt to survey
and project forward, based on organ sites, particu-
lar applications that could benefit from point-of-care
pathology. Second, we discuss the technical advances
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in optical hardware that are needed to translate in
vivo pathology into the clinic. Many of these advances
leverage the application of lasers to various forms
of imaging (and simultaneous treatment), and thus
exploit novel or unfamiliar optical contrast mecha-
nisms. Possibly the furthest along into the clinic is
optical coherence tomography (OCT) and its rela-
tive, optical coherence microscopy [23, 24]. These
reflectance microscopy techniques have overcome the
engineer-clinician chasm, achieving enormous pene-
tration in select areas. As they have been thoroughly
reviewed in the literature, we will not discuss them
in depth in this review. Photo-acoustic methods for
deep-tissue imaging, which rely upon the detection
of acoustic signals generated by optical absorption of
brief laser pulses [25, 26], is another extremely promis-
ing technology being translated into clinical use, but
will for the same reason not be covered here.
Additional novel microscope technologies being
applied clinically, but not for in vivo use, are also
worthy of mention. First, there are efforts to develop
ex vivo three-dimensional pathology devices for rapid
bedside microscopic imaging of fresh biopsy sam-
ples. Such devices could significantly improve clinical
care, for example, by expediting the performance of
Mohs micrographic resection of skin tumors [27, 28]
or the detection of residual disease at the surgical mar-
gins of breast cancer patients [29]. Efforts are also
ongoing to develop technologies for off-site pathol-
ogy diagnostics, with the potential to influence global
health challenges in resource-limited regions. Exam-
ples include the utilization of cell-phone cameras and
mobile networks for diagnoses of diseases [30] such
as malaria [31–33] and cervical cancer [34].
2. Specific clinical applications
Numerous academic and corporate research groups
are advancing the field of in vivo microscopy to address
point-of-care clinical needs, each with unique chal-
lenges in terms of imaging hardware, contrast agents,
regulatory approval, integration of these technologies
into the clinical and reimbursement workflow, and
patient acceptance. Such potential applications can
be roughly grouped into three categories: imaging
of accessible surfaces, endoscopic imaging of hollow
organs, and imaging during surgery or through inci-
sions. Table 1 provides examples of each, along with a
list of technical requirements that are relevant for each
application. Note that ophthalmic applications have
deliberately been left off of this list, as techniques such
as scanning laser ophthalmoscopy (SLO) have enjoyed
great success in the clinic and are not considered here
as an “unmet need” but rather as a model for translating
technologies to the clinic.
Common themes appear in Table 1 in terms of
both clinical and technical needs. As summarized in
the introduction, the predominant clinical paradigms
include the detection of diseases, image-guided biopsy,
and image-guided surgery or therapy. An additional
aim is to monitor responses to therapy, and to track the
recurrence of disease, through morphological and/or
molecular imaging of targeted contrast agents.
A major technical challenge is the miniaturiza-
tion of the devices to fit within small hollow organs,
within endoscope instrument channels, trocars (for
laparoscopy or core-needle biopsy), and within sur-
gical cavities. As far as detection is concerned, large
fields of view are always desired, either in individ-
ual image frames, or through the stitching together
(mosaicing) of overlapping image frames. In certain
cases, deep imaging depths may be desired – for exam-
ple, to monitor the physical penetration of a topically
applied chemical therapeutic, or to visualize the entire
mucosal (epithelial) layer of a hollow organ. The tech-
nical challenges listed in Table 1 are being addressed
in various ways, as described in the following section.
Figures 2 through 4 show examples of images obtained
in clinical and preclinical settings, from accessible
organs (Fig. 2), hollow organs (Fig. 3), and during
surgical procedures (Fig. 4).
3. Technical advances
Technical improvements specifically in microscopy-
based approaches will be required to advance in vivo
pathology, with requirements dictated by the geomet-
ric constraints imposed by the organ or tissue site, as
well as the distinguishing characteristics of the disease
targets. Important parameters include the dimensions
of the optical head, the flexibility of the tether, the tis-
sue imaging depth, the frame rate, spatial resolution,
field of view, detection modality, and the capability
to handle individual or multiple wavelengths. The fol-
lowing section outlines various design considerations
along with some current and future approaches towards
addressing unmet clinical needs. This section assumes
a basic understanding of confocal and multiphoton
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Table 1
Unmet clinical needs
Organ systems Clinical applications Technical requirements
Accessible organs
e.g. skin,
oropharynx
• Tumor margin detection (e.g. Mohs
surgery)
• Monitoring response to topical therapies
(e.g. siRNA delivery)
• Detection and staging of lesions
• Large fields of view
• Multi-color imaging of contrast agents tar-
geted to various disease biomarkers
• Improved label-free methods for obtaining
image contrast (e.g. reflectance and fluores-
cence spectroscopy, fluorescence lifetime
imaging)
• Large penetration depth for monitoring
delivery of therapeutics
• Ergonomic and flexible designs for ease of
use
Hollow organs via
endoscopy
e.g. esophagus,
stomach,
rectum,
intestine,
ampulla of
vater, uterine
cervix, bladder,
lungs
• Detection of dysplasia (pre-cancer)
• Staging of lesions
• Monitoring response to therapy (e.g. RF
ablation, photodynamic therapy)
• Image-guide biopsy and/or resection
• Endoscope-compatible design (miniatur-
ization)
• Large fields of view
• Multi-color imaging of contrast agents tar-
geted to various disease biomarkers
• Improved label-free methods for obtaining
image contrast
• Large penetration depth for interrogating
full-thickness mucosa (∼0.5 mm)
• High frame rates for monitoring physiolog-
ical processes (e.g. blood flow or transport
of contrast agents)
Surgically-
accessed organs
e.g. prostate,
ovaries, muscle,
bone, breast,
brain
• Detection and staging of disease
• Image-guided biopsy
• Image-guided resection at the margins
• Laparoscope-compatible design
• Large fields of view
• Multi-color imaging of contrast agents tar-
geted to various disease biomarkers
• Methods for minimally invasive insertion
• Improved label-free methods for obtain-
ing image contrast (e.g. autofluorescence,
second-harmonic generation)
• Incorporation with surgical-positioning
robotics
• Integration with therapy tools (e.g. suction
catheters, photodynamic therapy)
microscope technologies, as described in numerous
introductory and review articles [35–41]. While multi-
photon approaches have been popular for pre-clinical
investigations, confocal approaches have been pur-
sued more aggressively for clinical applications. This
is in part due to the fact that confocal designs tend
to be simpler, utilizing inexpensive low-power lasers
as opposed to the high-peak-power pulsed lasers and
dispersion-compensating optics and fibers required for
multiphoton-based systems.
3.1. Resolution, contrast, and imaging depth
In terms of in vivo pathology, the specific applica-
tion will dictate the requirement for spatial resolution.
For example, if detecting nuclear atypia is required,
then achieving sub-cellular resolution will be impor-
tant. Alternatively, if molecular imaging of cell-surface
proteins with targeted reagents is the goal, then
cellular-level resolution may be sufficient. As with res-
olution, image contrast is a critical variable to consider.
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Fig. 2. a: Neovascularization in a mouse model (with fluorescein angiography). Image taken in vivo with a Heidelberg Engineering HRA I
scanning laser ophthalmoscope. Arrow points to a well-defined lesion [110]. b: Microscopic imaging of the skin of a transgenic mouse model
with GFP expression in the footpad. In vivo image taken with 10-mm diameter, dual-axis confocal (DAC) microscope [111]. c: Confocal mosaic
of a micronodular basal cell carcinoma (BCC) obtained ex vivo. Individual images (430 by 430-m field of view) were combined to create
a large image of excised tissue with a 10- to 20-mm field of view. Small tumor nests (T) are shown as bright spots. Fluorescence emission
detected from acridine orange-stained nuclei using a VivaScope 2000 by Lucid, Inc. Scale bar indicates 1 mm [112]. d: Multiphoton microcopy
of intrinsic fluorescence contrast from healthy human skin at various depths. The false coloring shows the ratios of the amplitudes (a1/a2) of
the double-exponential fluorescence lifetime decay, a presumed indicator of metabolism [6].
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Fig. 3. a: Endomicroscopic image of a low-grade papillary tumor in a human bladder taken with a fibered confocal microscope (Mauna Kea
Technologies) consisting of a 2.6 mm diameter flexible probe. Laser illumination was transmitted through an imaging bundle of more than 30,000
optical fibers. The image was taken at a depth of 60m with a 240-m diameter FOV. Scale bar indicates 20m [113]. b: In vivo confocal
fluorescence image of the border between colonic adenoma and normal mucosa, showing peptide binding to dysplastic colonocytes. Image taken
in a human patient with the Cellvizio-GI imaging system by Mauna Kea Technologies, based on a fiber-bundle design [114]. c: Fibered confocal
fluorescence microscopy imaging of the alveoli in the lungs of a smoker during bronchoscopy. A 1.4-mm diameter Cellvizio-Lung prototype
was used (Mauna Kea Technologies), based on a fiber-bundle design. The field of view is 600m in diameter. Scale bar represents 50m [115].
d: Confocal image of the subsurface microvasculature of normal, descending human colon, collected in vivo following intravenous injection
of sodium fluorescein. The confocal microscope, developed jointly by Pentax and Optiscan, is permanently integrated into an endoscope and
utilizes a single fiber that is mechanically scanned with piezoelectrics. FOV = 500 × 500 microns [116].
Reflectance imaging often provides limited contrast,
since only structures with large differences in refrac-
tive index compared to the surrounding medium, such
as cell membranes and nuclei, can be easily visualized.
Fluorescence imaging of exogenously applied fluo-
rophores can generate enhanced contrast of selected
targets, provided that they bind specifically to those
targets and with high affinity, and that unbound probes
in the background are effectively cleared, or compen-
sated for [42]. As mentioned previously, activatable
probes that emit optical signals only when they bind to
or find themselves in the target region have great poten-
tial for increasing achievable signal-to-background
[7, 10–14]. However, in general, enthusiasm for exoge-
nous labeling approaches have to be tempered by
considerations of cost and time required to achieve
FDA approval and the difficulties of obtaining ade-
quate return on investment for their developers.
In certain clinical applications, imaging below the
surface may be necessary. For example, in tumor resec-
tion, molecular reagents may label subsurface cells
more accurately than surface cells that have been
surgically perturbed. Another example would be to
visualize dysplastic changes throughout the epithelial
layer of organs such as the colon, where the mucosa is
500m thick. Multiphoton microscopy, in particular,
J.T.C. Liu et al. / Point-of-care pathology with miniature microscopes 89
Fig. 4. a: In vivo image of GFP-expressing medulloblastoma in a mouse taken by a miniature dual-axis confocal microscope designed to guide
brain tumor resection (image depth is 30m). The design features a biaxial scanning MEMS mirror and a 2-mm diameter GRIN relay lens
[46]. b: In vivo images depicting epithelial cells that have an abnormal appearance, diagnosed as serous cystadenoma. FOV is 450 microns.
This image was taken with a confocal microscope designed into a laparoscopic device [117]. c: Image of a cultured mouse muscle fiber with
two-photon autofluorescence (red) and second-harmonic generation (green) from sarcomeres. A GRIN relay lens was used to access subsurface
muscle. Scale bar indicates 10m [61].
has demonstrated an ability to image relatively deeply
in a variety of tissues types. Where deep optical sec-
tioning is not required, however, conventional confocal
microscopy has been utilized to acquire high-contrast
microscopic images near the tissue surface (<100m
deep). A variant of conventional confocal microscopy
that utilizes low-NA lenses to image in both reflectance
and fluorescence modes is termed dual-axis confocal
(DAC) microscopy. This technique has demonstrated
improved optical sectioning with penetration depths
approaching that of multiphoton microscopy [43–45].
The DAC architecture can enable laser-scanned imag-
ing over relatively large fields of view with the use of
biaxial-scanning MEMS mirrors [46–48]. An alterna-
tive approach for imaging at shallow depths is to use
structured illumination to distinguish between signal
generated at the focal plane vs. signal generated else-
where [49–53]. This is a full-field imaging approach
that does not require beam scanning and is thus able
to achieve high frame rates, albeit at limited imaging
depths in tissues due to issues related to dynamic range
and shot noise.
Table 2 and Fig. 5 summarize some of the major
approaches for achieving optical sectioning in tissues.
3.2. Approaches towards miniaturization
The greatest constraint in the design of in vivo
microscopes is size. Optical-sectioning microscopes,
which are generally necessary for high-contrast high-
resolution cellular imaging in thick tissues, are
mature technologies as embodied in large bench-
top laboratory instruments. However, adaptation of
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Laser
Confocal Dual-axis confocal Two-photon Structured
illumination
Detector
CCD array
a b c d
Fig. 5. a: The conventional confocal microscope, using a high-NA (0.8–1.4) objective and two pinholes to provide a point source and point
detector. Images are collected by scanning the focal spot within the specimen in either reflectance or fluorescence (shown) modes. Excitation
light (blue) is absorbed by the fluorescent molecules in the specimen, and fluorescence emission (green) is collected by the point detector. b:
The dual-axis confocal microscope, using two low-NA (0.1–0.2) objective lenses and two pinholes to provide a point source and point detector.
The excitation (blue) and emission (green) beams are spatially separated within the specimen, except where they overlap at the focus. c: The
multiphoton microscope using a high-NA (0.8–1.4) objective and a single pinhole to provide a point source. The red beam represents the
long-wavelength excitation light (high-peak-power pulsed laser), which is non-linearly absorbed by the fluorescent molecules in the specimen.
The efficiency of two-photon absorption, for example, scales as the square of the intensity of the light, and is therefore confined to just the
focus of the excitation beam. The green beam represents the shorter-wavelength fluorescence emission light collected by a large area detector.
d: The structured illumination microscope can be used to gather full-field (single-shot) 2D images by a photodetector array (CCD) in either
reflectance or fluorescence (shown) modes. The images are quasi-optically-sectioned due to the fact that the structured pattern is only imaged
with high contrast at the focal plane within the specimen. By spatially modulating the illumination pattern, out-of-focus (low-contrast) light
may be distinguished from, and digitally filtered away from the in-focus light that is modulated with high contrast. The multiple blue beams
represent a pattern of excitation light beams emanating from a structured light source, which is absorbed by the fluorescent molecules in the
specimen. The respective green beams represent the fluorescence emission light collected by the CCD.
optical-sectioning microscopes for use in clinical set-
tings has necessitated creative approaches towards
miniaturization. In general, to achieve high spa-
tial resolution in microscopy, light must be focused
sharply into specimens using high-numerical-aperture
(NA) objectives, which are engineered to enable
aberration-free imaging over a field of view (FOV).
Multi-element compound miniature optics have been
developed, using conventional glass lenses as well as
injection-molded aspheric lenses, to enable uniform
telecentric imaging [54–56]. Gradient-index (GRIN)
optics, which are cylindrical components with small
diameters on the order of 1 mm, have also been utilized
for confocal endomicroscopy and multiphoton imag-
ing but are currently limited in NA to about 0.6 [46,
57–62]. Hybrid designs utilizing conventional optics
and GRIN lenses have been developed with larger NAs
of up to 0.8 [63], enabling both greater light collec-
tion and higher spatial resolution, while still enabling
a small overall probe size.
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Table 2
Major microscope modalities
Approach Pros Cons
Multiphoton High resolution and contrast; deep tissue penetration Expensive laser source; slow point scanning; need for
dispersion compensation
Structured
illumination
Fast full-field imaging with a camera; inexpensive light
source; no moving parts
Limited contrast and imaging depth in tissue due to high
shot-noise and limited dynamic range of detector
Conventional
confocal
Impressive miniaturization is possible through proximal
scanning into fiber bundles; inexpensive light source;
commercial devices exist
Limited contrast and imaging depth in tissue; high-NA
optics lead to short working distances and increased
potential for aberrations
Dual-axis
confocal
Efficient rejection of out-of-focus scattered light for
high contrast and deep tissue imaging; long working
distance; relatively isotropic resolution
Low-NA optics limit sensitivity; alignment of dual
beams may be challenging
Coherence gating Efficient rejection of out-of-focus scattered light for
high contrast and deep tissue reflectance imaging with a
long working distance
Limited to detection of coherence reflected light;
low-NA focusing limits lateral resolution
Non-sectioned Epi-fluorescence imaging provides fast full-field
imaging with a camera; inexpensive light source; no
moving parts
Poor contrast and imaging depth in tissue (no optical
sectioning)
In terms of packaging, a number of design
approaches have been explored to bring miniature
microscopes into the clinic, some of which rely on
optical fiber components.
3.2.1. Non-fibered approach
One approach towards in vivo microscopy has
been to retrofit large, non-fibered systems with
long-working-distance objectives or miniature optics,
such as GRIN lenses, for imaging in animals and
humans. This approach, commonly termed intravi-
tal microscopy, has been instrumental in enabling a
number of landmark studies in immunology, stem-
cell biology, cancer, and other diseases [61, 64–68].
Surgically implanted window models have been devel-
oped in animals to provide long-term optical access to
tissues; alternatively, miniature GRIN-lens microen-
doscopes have been inserted into deep tissues for
long-term imaging studies. One recent application of
intravital microscopy has been to perform line scans
across individual vessels, or groups of blood vessels,
to monitor the passage of fluorescently labeled cells
over time [65, 69–71]. This “in vivo flow cytometry”
technique has been used for multicolor investigations
of various cell types, including circulating tumor cells,
immune cells, and hematopoietic stem cells. The large
size and reduced flexibility of these non-fiber-based
approaches has made the clinical translation of such
devices challenging, except for certain applications in
which optical access is unrestricted, such as in the skin
and eyes.
3.2.2. Fiber-bundle vs. single-fiber approaches
Two major forms of miniature flexible microscope
designs have emerged: those that utilize an imaging
fiber-bundle approach and those that utilize a single
optical fiber for delivering laser illumination and for
signal collection. Fiber bundles are useful in that the
optical scanning mechanism can be located at the prox-
imal end of the system and thus outside of the patient
or animal subject. Each individual fiber in the bun-
dle is imaged to a unique point within the sample.
By illuminating and collecting light from one fiber at
a time, a 2D image may be reconstructed. The fiber-
bundle approach has the advantage of requiring few or
no moving parts within the distal optical head, which
allows for impressive miniaturization of the endomi-
croscope to sub-millimeter dimensions in some cases
[1, 5, 54, 55, 72–77]. However, such devices generally
image at a single depth, since axial scanning would
require the addition of a linear actuator within the dis-
tal scan head to adjust the position of the focusing
optics, thus limiting the extent of miniaturization [56,
78]. Several non-confocal versions of this technology
have been developed for rapid full-field (non-scanned)
camera-based imaging of tissue surfaces [5, 19, 79,
80]. This approach is a favorable choice if high-speed,
compact, and inexpensive imaging of a tissue sur-
face is preferred rather than high-contrast subsurface
imaging.
In contrast, single-fiber approaches rely upon micro-
optics and scanning mechanisms integrated into the
distal optical head of the endomicroscope to enable 2D
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Table 3
Approaches to miniaturization
Approach Applications Pros Cons
Non-fibered – Chronic intravital microscopy with
window preparations
– GRIN lenses inserted in tissue
– In vivo flow cytometry
– Diffraction-limited and achro-
matic optics
– Limited requirements for mini-
aturization
– Accessibility into the body is
limited
– Poor clinical portability
Fiber bundle – Proximally scanned confocal mic-
roscopy
– Nonconfocal, full-field microscopy
of tissue surfaces with fast cameras
– Proximal scanning
– High degree of miniaturization
– Rapid full-field imaging
is possible
– Fixed imaging depth at the sur-
face or at one working distance
– Fiber spacing may limit lateral
resolution
Single fibers – Distal scanning with MEMS mir-
rors and resonant mechanical scan-
ners
– Spectrally encoded scanning
– Diffraction-limited distal scan-
ning; axial scanning may be
possible
– Distal scanning limits the extent
of miniaturization
or even 3D imaging. Two major strategies have been
used to accomplish this: micro-electro-mechanical
systems (MEMS) scanning mirrors [46, 48, 81–87],
and mechanical fiber/optical component deflectors
[88–92]. An alternative method for achieving distal
scanning has been achieved in a miniature microscope
through the use of spectral encoding, in which the
wavelength components of a broadband light source
are mapped along one dimension or two dimensions
with a diffractive optical element such as a prism or
grating [93–96]. This eliminates the need for scan-
ning along those dimensions. However, it has been
largely limited to reflectance imaging since fluores-
cence emission is broadband, where spatial positions
cannot efficiently be encoded by wavelength compo-
nents [79, 97].
Table 3 and Fig. 6 summarize some of the major
approaches towards the miniaturization and scanning
of in vivo microscopes.
3.3. Achromatic designs
The ability to simultaneously image at multiple
wavelengths is extremely important in many appli-
cations. Multi-color fluorescence microscopy allows
for the observation of interactions and correlations
between labeled cells and tissue components [64–68,
98–101] as well as for the ratiometric quantification
of image intensities [42, 102–104]. Color-corrected
micro-objectives have been developed for in vivo
devices [54–56]. Diffractive optical elements may also
be used to compensate for the effects of chromatic
dispersion and are being explored for the develop-
ment of achromatic GRIN lenses [B. Messerschmidt,
GRINTECH GmbH, personal communication] and
microscope systems. Often, these approaches may
require a sacrifice in diffraction-limited performance
and resolution in order to achieve effective color cor-
rection.
3.4. Clinical deployment
Clinical considerations such as ease of use and
ergonomics cannot be overlooked in the design of
instruments for in vivo pathological assessment. As
these technologies continue to mature, various refine-
ments will be necessary to encourage clinical adoption,
such as the integration of POC microscopes into exist-
ing devices. For example, in image-guided surgery
applications, miniature microscopes could be inte-
grated with therapeutic tools such as tumor suction
catheters for co-localized image detection and treat-
ment. In other cases, POC microscopes could be
designed to be deployed through existing platforms,
such as the instrument channels in conventional
endoscopes and laparoscopes. Additional clinical con-
siderations include the ease of sterilization, the lifetime
of the device, and the availability of disposable
components. Robotic-assisted surgery, although not
yet shown to improve outcome, is maturing and is
predicted to increase in clinical use. Integration of
in vivo microscopes with surgical robots would be
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Fig. 6. a: The spectrally-encoded scanning mechanism disperses a broadband beam into multiple beams, based on wavelength, which are
projected at different angles towards the objective lens, which in-turn produces a sequence of focused points along a linear path within the
specimen. A line scan is achieved rapidly in one direction by either scanning the wavelength of the laser source, or by using a broadband light
source. In the latter case, the reflected light that is collected must be analyzed with a spectrograph in order to decode spatial location from
the wavelength components of the signal. b: The resonant fiber scanning mechanism uses the end of a single-mode fiber to serve as both the
point source and point detector of a confocal microscope. This system can be used to gather an image by providing a mechanism for vibrating
(deflecting) the end of the fiber in a resonant sinusoidal pattern to scan the focal spot within the specimen. The blue beam represents the excitation
light, which is absorbed by the fluorescent molecules in the specimen. The green beam represents the fluorescence emission light collected by
the end of the fiber and then directed to a detector. c: The fiber-bundle scanning mechanism uses the ends of multiple fibers to provide multiple
point sources and point detectors for a large number of parallel confocal microscopes, each imaging a single point (pixel) within a 2D image.
Beam scanning is performed on the proximal end of the fiber bundle (away from the patient) where each fiber is illuminated sequentially in
time. d: A miniature dual-axis confocal microscope is depicted, where a fast electrostatically driven MEMS scanning mirror steers the excitation
and emission beams along two orthogonal directions for 2D imaging. Two separate single-mode fibers act as a point source and point detector,
respectively.
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especially beneficial since motion-induced imaging
artifacts could be greatly attenuated.
While the subject of software development is beyond
the scope of this review, key components in the clinical
translation of any in vivo imaging device will include
optimizing what is presented to the proceduralist and
pathologist (if involved), and the development of
image-processing algorithms to assist in interpreta-
tion. Among the greatest challenges that will confront
imaging scientists, particularly in biomedicine and
regardless of modality or dimensional scale, will be to
understand how best to combine the virtues of auto-
mated analysis with the power of a trained human
visual observer. In a field as variable and complex
as pathology, for instance, our goal, in the short- to
medium-term, should not be to entirely replace human
image interpretation, but rather to find ways to optimize
the presentation of image data to reduce observer bias
and to increase the accuracy and efficiency of analysis.
3.5. Translational considerations
Optical coherence tomography (OCT) is an exam-
ple of the successful translation of a non-invasive
optical technology to broad application in the medi-
cal practice market [105, 106]. This market extends
beyond the field of ophthalmology into gastroenterol-
ogy, dermatology, urology, otolaryngology, and others.
Lessons learned from its successful implementation
include: (a) approval by the Food and Drug Adminis-
tration (FDA) for clinical utilization; (b) inclusion of
the FDA-approved technology in Medicare and Med-
icaid reimbursement schedules; (c) ease of use and
incorporation into the clinical workflow; (d) develop-
ment of professional and technical expertise amongst
healthcare providers; (e) development of a strong evi-
dence base for successful clinical management; and
(f) robust interest from the commercial sector in con-
tinued investment in this technology.
Any novel technique of in situ microscopy will
encounter four major challenges [107]:
1) Analytical utility: does the technology measure
what it claims to measure?
2) Clinical relevance: does the technology answer
the clinical question being asked?
3) Clinical effectiveness: does use of the technology
lead to better patient outcomes [108]?
4) Social value: does the technology meet ethical,
economic, and legal standards?
Extensive effort is currently underway to answer
the first three questions of the “validation” issue. The
overall translational challenges are discussed by Wells
et al. [109], who noted that, until primary evidence
from the field can be developed, optical technolo-
gies must depend on histopathologic evaluation as a
“gold standard” for the validation of analytical and
clinical utility. Hence, the potentially flawed technol-
ogy of histopathology remains as a validation portal
through which optical technologies, including point-
of-care pathology, must pass.
4. Summary
The field of in vivo pathology, enabled by advances
in optics, sensors and electronics, is rapidly evolving
and being translated into various clinic arenas. Since
there is often a disconnect between the clinical end
users and the engineers and scientists developing the
core technologies, we have attempted to do two things:
to outline some of the major clinical needs and scenar-
ios for which in vivo pathology can be effective, as well
as to summarize the major technical approaches and
challenges in meeting those needs. Each specific clini-
cal application will necessitate its own set of design
choices that will require extensive communication
between physicians and those developing the technolo-
gies. Since complex issues are not easily summarized,
this article discusses a limited set of challenges,
including the integration of these techniques into the
clinical workflow, the use of contrast agents, regulatory
approval, reimbursement, robotic aids, and an infras-
tructure for telepathology. Nonetheless, we hope that
discussions such as this can provide a useful framework
for progress along this exciting new frontier.
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